
Please try another search
LePU Biopharma Co Ltd is a China-based biopharmaceutical company focused on tumor treatment. The Company mainly develops product lines of tumor candidate drugs, including antibody drug conjugate (ADC), oncolytic virus drug products and immunotherapy at clinical and pre-clinical stages. The Company’s major pipeline assets consist of MRG003, MRG002, HX008 and LP002, and three key clinical-stage drug candidates. The Company's products are sold at home and abroad.
Name | Age | Since | Title |
---|---|---|---|
Zhongjie Pu | 58 | 2018 | Executive Chairman |
Demin Zhou | 54 | 2020 | Independent Non-Executive Director |
Ziye Sui | 41 | 2020 | CEO & Director |
Haifeng Yang | 44 | 2020 | Independent Non-Executive Director |
Jue Pu | 32 | 2020 | Non-Executive Director |
Chaohong Hu | 55 | 2020 | Co-CEO & Director |
Xianghong Lin | 51 | 2020 | Non-Executive Director |
Fengmao Hua | 53 | 2021 | Independent Non-Executive Director |
Hongbing Yang | 52 | 2020 | Non-Executive Director |
Yang Xu | 55 | 2020 | Supervisor |
Jiwei Wang | 34 | 2020 | Supervisor |
Ming Yang | 55 | 2020 | Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review